Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice-Reference-Cited by-同舟云学术

Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice

Published:2016-02-10 Issue:3 Volume:79 Page:387-403
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Capone Carmen¹²,Cognat Emmanuel¹²,Ghezali Lamia¹²,Baron-Menguy Céline¹²,Aubin Déborah¹²,Mesnard Laurent³⁴,Stöhr Heidi⁵,Domenga-Denier Valérie¹²,Nelson Mark T.⁶⁷,Joutel Anne¹²

Affiliation:

1. Genetics and Pathogenesis of Cerebrovascular Diseases; Inserm, U1161 and Univ Paris Diderot, Sorbonne Paris Cité, UMRS 1161, F-75010; Paris France

2. DHU NeuroVasc, Sorbonne Paris Cité; Paris France

3. Rare and Common Kidney Diseases, Matrix Remodeling and Tissue Repair; Inserm U1155 and Pierre and Marie Curie University, Sorbonne Universities UMR-S 1155, F-75020; Paris France

4. Department of Emergency Nephrological and Renal Transplantation; Tenon Hospital, AP-HP, F-75020; Paris France

5. Institute of Human Genetics; University of Regensburg; Regensburg Germany

6. Department of Pharmacology, College of Medicine; University of Vermont; Burlington VT

7. Institute of Cardiovascular Sciences; University of Manchester; Manchester United Kingdom

Funder

National Research Agency, France

NIH

Totman Medical Research Trust

Leducq Foundation

National Institute of Health and Medical Research

Publisher

Wiley